Keywords: genetronics, signs, deal, ethicon, canada, biomedical, entered
Genetronics Signs Deal With Ethicon
Article | 07 October 1998
Canada's Genetronics Biomedical has entered into a licensing and supplyagreement on its proprietary drug delivery system for electroporation therapy treatment ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- New study shows UCB's Neupro reduces NSBP in RLS patient
